Published in Ann Emerg Med on May 03, 2007
Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol (2008) 3.63
Trends in stroke incidence, mortality and case fatality rates in Joinville, Brazil: 1995-2006. J Neurol Neurosurg Psychiatry (2009) 1.69
The "golden hour" and acute brain ischemia: presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset. Stroke (2010) 1.50
Thrombolytic utilization for ischemic stroke in US hospitals with neurology residency program. Neurology (2013) 1.44
A concerted appeal for international cooperation in preclinical stroke research. Stroke (2013) 1.32
Provider perceptions of barriers to the emergency use of tPA for acute ischemic stroke: a qualitative study. BMC Emerg Med (2011) 1.15
Gender differences in the functional recovery after acute stroke. J Clin Neurol (2010) 1.15
Response to symptoms of stroke in the UK: a systematic review. BMC Health Serv Res (2010) 1.10
Intravenous tissue plasminogen activator and stroke in the elderly. Am J Emerg Med (2010) 0.98
Too good to treat? Outcomes in patients not receiving thrombolysis due to mild deficits or rapidly improving symptoms. Int J Stroke (2011) 0.94
Community-based participatory research: a new approach to engaging community members to rapidly call 911 for stroke. Stroke (2011) 0.93
Safety of intravenous thrombolytic use in four emergency departments without acute stroke teams. Acad Emerg Med (2010) 0.91
Thrombolytic therapy for acute ischemic stroke beyond three hours. J Emerg Med (2010) 0.90
Variability in the use of intravenous thrombolysis for mild stroke: experience across the SPOTRIAS network. J Stroke Cerebrovasc Dis (2011) 0.89
Enhancing community delivery of tissue plasminogen activator in stroke through community-academic collaborative clinical knowledge translation. Emerg Med Clin North Am (2009) 0.88
Time to brain imaging in acute stroke is improving: secondary analysis of the INSTINCT trial. Stroke (2013) 0.87
Mild stroke and rapidly improving symptoms: it's not always a happy ending. Stroke (2011) 0.85
Stroke warning campaigns: delivering better patient outcomes? A systematic review. Patient Relat Outcome Meas (2015) 0.84
Racial Disparities in Intravenous Recombinant Tissue Plasminogen Activator Use Persist at Primary Stroke Centers. J Am Heart Assoc (2015) 0.84
Intravenous thrombolysis in the emergency department for the treatment of acute ischaemic stroke. Emerg Med J (2008) 0.82
Blood glutathione S-transferase-π as a time indicator of stroke onset. PLoS One (2012) 0.81
Lack of association between pretreatment neurology consultation and subsequent protocol deviation in tissue plasminogen activator-treated patients with stroke. Stroke (2010) 0.78
CT perfusion cerebral blood volume does not always predict infarct core in acute ischemic stroke. Neurol Sci (2015) 0.77
Individual and System Contributions to Race and Sex Disparities in Thrombolysis Use for Stroke Patients in the United States. Stroke (2017) 0.76
Race and sex disparities in prehospital recognition of acute stroke. Acad Emerg Med (2015) 0.75
Imaging of prehospital stroke therapeutics. Expert Rev Cardiovasc Ther (2015) 0.75
Detection of Early Ischemic Changes in Noncontrast CT Head Improved with "Stroke Windows". ISRN Neurosci (2014) 0.75
Case Volume-Outcomes Associations Among Patients With Severe Sepsis Who Underwent Interhospital Transfer. Crit Care Med (2017) 0.75
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (2010) 11.25
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2014) 10.06
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol (2014) 9.96
Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension (2006) 8.72
Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep (2005) 8.15
Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med (2008) 7.25
Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med (2012) 6.60
Transient ischemic attack--proposal for a new definition. N Engl J Med (2002) 4.94
Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation (2002) 4.69
Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. Sleep (2007) 4.14
Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation (2005) 4.08
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke (2008) 4.06
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Morning increase in onset of ischemic stroke. Stroke (1989) 3.52
Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA (2004) 3.51
Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis. Arch Intern Med (2012) 3.50
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology (2006) 3.46
Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med (1992) 3.38
Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation (2005) 3.25
Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials. Stroke (2008) 3.21
The Harvard Cooperative Stroke Registry: a prospective registry. Neurology (1978) 3.19
Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation (2012) 3.14
Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol (1989) 3.13
The Stroke Data Bank: design, methods, and baseline characteristics. Stroke (1988) 3.12
The risk and outcomes of epidural hematomas after perioperative and obstetric epidural catheterization: a report from the Multicenter Perioperative Outcomes Group Research Consortium. Anesth Analg (2012) 3.12
The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation (2011) 2.89
National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol (2006) 2.82
Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis--not a panacea for ischemic stroke. N Engl J Med (1997) 2.82
Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study. Stroke (2004) 2.76
MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke (2004) 2.75
Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstet Gynecol (2014) 2.67
Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke (2013) 2.66
Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. Stroke (2007) 2.55
Moderate alcohol consumption reduces risk of ischemic stroke: the Northern Manhattan Study. Stroke (2005) 2.51
Ideal cardiovascular health predicts lower risks of myocardial infarction, stroke, and vascular death across whites, blacks, and hispanics: the northern Manhattan study. Circulation (2012) 2.48
Relationship between periodontal disease, tooth loss, and carotid artery plaque: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Stroke (2003) 2.45
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol (2012) 2.44
Broca aphasia: pathologic and clinical. Neurology (1978) 2.43
The New York Islands AVM Study: design, study progress, and initial results. Stroke (2003) 2.42
Aortic arch plaques and risk of recurrent stroke and death. Circulation (2009) 2.40
Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. JAMA (2012) 2.38
Stroke in the young in the northern Manhattan stroke study. Stroke (2002) 2.37
Patent foramen ovale and stroke. Circulation (2005) 2.34
Traditional risk factors are not major contributors to the variance in carotid intima-media thickness. Stroke (2013) 2.34
Relation of plasma glucose and endothelial function in a population-based multiethnic sample of subjects without diabetes mellitus. Am J Cardiol (2005) 2.34
Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study. Stroke (2009) 2.33
The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesth Analg (2010) 2.32
Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan Study. Stroke (2007) 2.30
Central poststroke pain and Wallenberg's lateral medullary infarction: frequency, character, and determinants in 63 patients. Neurology (1997) 2.28
Neurologic deterioration in noncomatose patients with supratentorial intracerebral hemorrhage. Neurology (1994) 2.21
Intracerebral hemorrhage: external validation and extension of a model for prediction of 30-day survival. Ann Neurol (1991) 2.20
Left ventricular mass and geometry and the risk of ischemic stroke. Stroke (2003) 2.15
Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol (2007) 2.15
The natural history of CADASIL: a pooled analysis of previously published cases. Stroke (1999) 2.14
Perioperative acute ischemic stroke in noncardiac and nonvascular surgery: incidence, risk factors, and outcomes. Anesthesiology (2009) 2.12
Infectious burden and risk of stroke: the northern Manhattan study. Arch Neurol (2009) 2.08
Stroke literacy in Central Harlem: a high-risk stroke population. Neurology (2009) 2.06
Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 2.06